2022
DOI: 10.1080/15360288.2022.2084209
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Guideline-Recommended Pain Management in Acute Sickle Cell Crisis and Its Effect on Patient Outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 14 publications
0
1
0
Order By: Relevance
“…The institutionalization of a healthcare center dedicated to providing personalized care for patients with SCD is one of these recently developed methods. A sickle cell infusion clinic (SCIC), affiliated with the Johns Hopkins Hospital, showed a significant reduction in hospital admission rates from the ED when compared to the year prior to institutionalization and the year after [11][12][13]. The ESCAPED trial is an ongoing multi-center prospective cohort study, which has so far shown a substantial reduction in hospitalizations for those who were treated in SCICs compared to those who were treated in the ED (relative risk reduction (RRR) of 75%, p < 0.001) [14].…”
Section: Discussionmentioning
confidence: 99%
“…The institutionalization of a healthcare center dedicated to providing personalized care for patients with SCD is one of these recently developed methods. A sickle cell infusion clinic (SCIC), affiliated with the Johns Hopkins Hospital, showed a significant reduction in hospital admission rates from the ED when compared to the year prior to institutionalization and the year after [11][12][13]. The ESCAPED trial is an ongoing multi-center prospective cohort study, which has so far shown a substantial reduction in hospitalizations for those who were treated in SCICs compared to those who were treated in the ED (relative risk reduction (RRR) of 75%, p < 0.001) [14].…”
Section: Discussionmentioning
confidence: 99%